- Home
- PYXS vs NVX Comparison
PYXS vs NVX Comparison
Compare PYXS & NVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYXS
- NVX
- Stock Information
- Founded
- PYXS 2018
- NVX 2012
- Country
- PYXS United States
- NVX Australia
- Employees
- PYXS N/A
- NVX N/A
- Industry
- PYXS Biotechnology: Pharmaceutical Preparations
- NVX Industrial Machinery/Components
- Sector
- PYXS Health Care
- NVX Miscellaneous
- Exchange
- PYXS Nasdaq
- NVX Nasdaq
- Market Cap
- PYXS 210.4M
- NVX 232.1M
- IPO Year
- PYXS 2021
- NVX N/A
- Fundamental
- Price
- PYXS $4.19
- NVX $2.01
- Analyst Decision
- PYXS Strong Buy
- NVX Strong Buy
- Analyst Count
- PYXS 7
- NVX 1
- Target Price
- PYXS $9.57
- NVX $4.00
- AVG Volume (30 Days)
- PYXS 706.7K
- NVX 60.4K
- Earning Date
- PYXS 11-12-2024
- NVX 01-01-0001
- Dividend Yield
- PYXS N/A
- NVX N/A
- EPS Growth
- PYXS N/A
- NVX N/A
- EPS
- PYXS N/A
- NVX N/A
- Revenue
- PYXS $16,146,000.00
- NVX $6,875,112.00
- Revenue This Year
- PYXS N/A
- NVX $89.31
- Revenue Next Year
- PYXS N/A
- NVX $410.89
- P/E Ratio
- PYXS N/A
- NVX N/A
- Revenue Growth
- PYXS N/A
- NVX 19.05
- 52 Week Low
- PYXS $1.35
- NVX $1.40
- 52 Week High
- PYXS $6.85
- NVX $3.10
- Technical
- Relative Strength Index (RSI)
- PYXS 56.86
- NVX 51.26
- Support Level
- PYXS $3.88
- NVX $2.05
- Resistance Level
- PYXS $5.39
- NVX $2.29
- Average True Range (ATR)
- PYXS 0.31
- NVX 0.12
- MACD
- PYXS 0.04
- NVX 0.01
- Stochastic Oscillator
- PYXS 34.43
- NVX 53.61
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
About NVX NOVONIX Limited American Depository Shares
NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration and Mining, Battery Technology, and NOVONIX Anode Materials. Graphite Exploration and Mining segment is engaged in the exploration and development of high-grade flake graphite deposits. The NOVONIX Anode Materials segment develops and manufactures battery anode materials. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Technology segment generates maximum revenue for the company.